Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

KamRAB/KedRAB (rabies immunoglobulin human) for the Treatment of Rabies

Drug (Brand / Generic)

KamRAB/KedRAB / rabies immunoglobulin human

Company / Licensee

Kamada / Kedrion Biopharma

Current Indication

Passive, transient post-exposure prophylaxis of rabies

Market Sector

Anti-infective

Development Status

Approved in the US
Expand

Go Top